Captopril is an orally active inhibitor of angiotensin-converting enzyme (ACE) and has been
widely studied in the treatment of patients with mild to moderate essential hypertension …

Objective Information on the frequency of drug combinations with the potential to induce
dangerous drug–drug interactions (DDIs) in patients discharged from the hospital is scarce …

This review will discuss the safety profiles of the angiotensin-converting enzyme (ACE)
inhibitors captopril, enalapril and lisinopril in patients with hypertension. In general, the …

Since their introduction in clinical practice in 1980, ACE inhibitors have been found useful in
the treatment of hypertension and CHF. In hypertension, they are effective as monotherapy …

Abstract Endothelin-1 (ET-1) regulates vascular tone in congestive heart failure and
modulates renal function. Its role in patients with normal left ventricular (LV) function and its …

This report reviews the tolerability profile of enalapril, an angiotensin-converting enzyme
(ACE) inhibitor, in the treatment of patients with congestive heart failure. Data have been …

The relationships between blood pressure and renal function were investigated in 78
hypertensive patients with diabetes mellitus type I or II. Renal function was assessed by …

24 as enfermedades cardiovasculares son la principal causa de muerte a nivel mundial,
siendo la hipertensión arterial (HTA) el factor de riesgo más frecuente Objetivo: Determinar …

Side effects of angiotensin converting enzyme (ACE) inhibitors are not common with
currently recommended doses. Hypotension, hyperkalemia and renal impairment may occur …

Enalapril maleate (MK‐421) is a new non‐sulfhydryl‐containing converting‐enzyme
inhibitor that has been shown to be effective and well tolerated in patients with essential …